Form 4 for ATYR aTYR PHARMA INC
Accepted 2022-01-10 00:00:00 ET · period of report 2022-01-07 · accession 0001209191-22-002768 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-10 | 2022-01-07 | ATYR | Shukla Sanjay | Pres, CEO, Dir | P - Purchase | $6.76 | +5,000 | 25.8K | +24% | +$33.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-07 | P | A | 5,000 | $6.76 | 25,798 | D | — | — |